©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 115744
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.115744
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.115744
Table 2 Blood and bile culture data of patients undergoing percutaneous cholecystostomy (n = 174), n (%)
| Microorganism | Blood culture | Bile culture |
| Escherichia coli | 14 (8) | 36 (21) |
| Enterococcus species | 3 (2) | 18 (10) |
| Klebsiella pneumoniae | 6 (3) | 26 (15) |
| Enterobacter | 1 (1) | 9 (5) |
| Acinetobacter | 0 (0) | 3 (2) |
| Clostridium perfrigens | 2 (1) | 3 (2) |
| No growth | 125 (72) | 61 (35) |
- Citation: Hassanesfahani M, Giannis D, Marfo N, Kaur M, Quang CMPT, Miele A, Louis MA, Mandava NR. Defining endpoints in percutaneous cholecystostomy: Catheter management, patient survival, and long-term outcomes from a twelve-year retrospective study. World J Gastrointest Surg 2026; 18(2): 115744
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/115744.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.115744